Live Breaking News & Updates on Kosuke Ebina

Stay updated with breaking news from Kosuke ebina. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TNF, CTLA4-Ig Treatment Associated with Higher Discontinuation Rates in RA

Patients receiving TNF, JAK, and CTLA4-Ig all demonstrated higher discontinuation rates due to ineffectiveness when compared to aIL-6R treatment. ....

Japan General , Kosuke Ebina , Researchgate Kosuke Ebina , Department Of Musculoskeletal Regenerative Medicine , Kansai Consortium For , Musculoskeletal Regenerative Medicine , Osaka University Faculty , Medicine Graduate School , Kansai Consortium , Rheumatic Disease Patients ,